Loading clinical trials...
Loading clinical trials...
The purpose of this study is to find out what patients consider when deciding whether or not to receive adjuvant treatment, and how patients feel about their decision after one year.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Memorial Sloan Kettering Cancer Center
NCT05039801 · Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, and more
NCT06391099 · Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, and more
NCT06673095 · Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
NCT06999980 · Cutaneous Melanoma, Mucosal Melanoma
NCT07230613 · Cutaneous Melanoma, Stage III, Mucosal Melanoma
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions